Oceania Healthcare (ASX:OCA, NZE:OCA) said new sales volumes increased 29% and resales volumes rose 6% in the third quarter of the fiscal year compared with the prior-year period, according to Wednesday releases with the Australian and New Zealand bourses.
It is continuing to divest non-core sites and it is establishing a centralized team to support the delivery of long-term savings, expected to be in the range of NZ$10 million to NZ$15 million annually, reflecting the right sizing of support functions in light of divestments.
A NZ$5 million annualized cost right sizing program was completed and benefits from it are expected to be realized from fiscal 2026.
It also completed a refinance of debt facilities on Tuesday, March 4.
The firm's shares rose 6% in early trading on Wednesday on the New Zealand bourse and fell 2% on the Australian bourse.
Price (AUD): $0.60, Change: $-0.010, Percent Change: -1.64%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。